- Home
- / NextPoint Therapeutics
NextPoint Therapeutics
Total Funding
$80 M
NextPoint Therapeutics Summary
Company Summary
- Overview
- NextPoint Therapeutics is a biotechnology company that develops precision immuno-oncology. It provides monotherapies for patients who do not benefit from PD-1/L1 inhibitors.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://nextpointtx.com/
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Scott Chappel, Chief Scientific Officer
Paul Conrad, Chief Business Officer
Briggs W. Morrison, Interim Chief Medical Officer
LocationsView all
2 locations detected
Cambridge, MA HQ
United States
238 Main St #5th
Cambridge, MA
United States
450 Kendall St